Lower Limb ExoNET: Development and Evaluation for Gait Assistance With Stroke Survivors

Launched by SHIRLEY RYAN ABILITYLAB · May 22, 2025

Keywords

ClinConnect Summary

The Lower Limb ExoNET clinical trial is studying a new type of wearable device called the LegExoNET, designed to help people who have difficulty walking after a stroke. This device is a lightweight exoskeleton that uses elastic energy to assist movement while allowing natural movement of the joints. Unlike traditional robotic systems that can be expensive and invasive, the LegExoNET aims to provide both support and therapeutic training to improve walking skills, making it easier for stroke survivors to regain their independence. Initially, the trial will focus on healthy adults to ensure the device is safe and effective before testing it with stroke survivors.

To participate in the trial, individuals must be between 18 and 70 years old and able to walk without help for at least two hours. However, people with a history of stroke or other serious neurological conditions, pregnant individuals, and those with certain medical issues or skin problems are not eligible. Participants will have the chance to help evaluate this innovative technology, which could lead to better rehabilitation options for those recovering from stroke.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18-70 years old
• • Ability to provide informed consent
• • Capable of ambulating without the use of assistive devices for 2 hours
• Exclusion Criteria:
• • History of stroke, SCI, or other neurological medical diagnoses
• • Pregnant
• • Severe medical diagnoses (e.g. cardiovascular, orthopedic)
• • Skin allergies or irritation; open wounds
• • Prisoners
• • Cognitively impaired adults